Genome organization and the role of centromeres in evolution of the erythroleukaemia cell line HEL

We describe in detail the abnormal chromosomes of HEL, a human leukaemia cell line grown in many laboratories. Complementary high resolution and whole chromosome analysis tools, including the localisation of repetitive DNA sequences on intact chromosomes, are essential for understanding genome remodelling and evolution in cancer cells.

[1]  L. Campbell,et al.  Chromothripsis under the microscope: a cytogenetic perspective of two cases of AML with catastrophic chromosome rearrangement. , 2013, Cancer genetics.

[2]  A. Kohlmann,et al.  TET2 deletions are a recurrent but rare phenomenon in myeloid malignancies and are frequently accompanied by TET2 mutations on the remaining allele , 2012, British journal of haematology.

[3]  L. Campbell,et al.  Unbalanced translocations of 20q in AML and MDS often involve interstitial rather than terminal deletions of 20q. , 2011, Cancer genetics.

[4]  L. Campbell,et al.  The paradox of 20q11.21 amplification in a subset of cases of myeloid malignancy with chromosome 20 deletion , 2010, Genes, chromosomes & cancer.

[5]  S. Yu,et al.  Telomere Capture as a Frequent Mechanism for Stabilization of the Terminal Chromosomal Deletion Associated with Inverted Duplication , 2010, Cytogenetic and Genome Research.

[6]  L. Campbell,et al.  Dicentric chromosomes and 20q11.2 amplification in MDS/AML with apparent monosomy 20 , 2008, Cytogenetic and Genome Research.

[7]  J. Batanian,et al.  Coexistence of neocentromeric marker 3q and trisomy 3 in two different tissues in a 3-year-old boy with peripheral T-cell lymphoma: support for a gene dosage effect hypothesis. , 2006, Cancer genetics and cytogenetics.

[8]  Gaëlle Pérot,et al.  Molecular cytogenetic characterization of a metastatic lung sarcomatoid carcinoma: 9p23 neocentromere and 9p23-p24 amplification including JAK2 and JMJD2C. , 2006, Cancer genetics and cytogenetics.

[9]  H. Drexler,et al.  JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders , 2006, Leukemia.

[10]  L. Campbell,et al.  A comparison of two contrasting recurrent isochromosomes 20 found in myelodysplastic syndromes suggests that retention of proximal 20q is a significant factor in myeloid malignancies. , 2005, Cancer genetics and cytogenetics.

[11]  E. Estey,et al.  JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia. , 2005, Blood.

[12]  Sandra A. Moore,et al.  Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. , 2005, Cancer cell.

[13]  D. Christiansen,et al.  Amplification or duplication of chromosome band 21q22 with multiple copies of the AML1 gene and mutation of the TP53 gene in therapy-related MDS and AML , 2005, Leukemia.

[14]  S. Jhanwar,et al.  Identification of candidate genes on chromosome band 20q12 by physical mapping of translocation breakpoints found in myeloid leukemia cell lines , 2001, Oncogene.

[15]  T. L. Hood,et al.  Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes , 2000, Oncogene.

[16]  P. Wang,et al.  Refinement of the smallest commonly deleted segment of chromosome 20 in malignant myeloid diseases and development of a PAC-based physical and transcription map. , 2000, Genomics.

[17]  L. Nagarajan,et al.  Deletions of chromosome 5q13.3 and 17p loci cooperate in myeloid neoplasms. , 2000, Blood.

[18]  R. Bataille,et al.  Amplification of the 11q23 region in acute myeloid leukemia , 1999, Genes, chromosomes & cancer.

[19]  T. L. Hood,et al.  Identification of multiple copies of a 20q-chromosome in a case of myelodysplastic syndrome: a FISH study. , 1999, Leukemia research.

[20]  M. Tschan,et al.  Aberrant FHIT mRNA transcripts are present in malignant and normal haematopoiesis, but absence of FHIT protein is restricted to leukaemia , 1999, Oncogene.

[21]  M. Seto,et al.  Amplification on double‐minute chromosomes and partial‐tandem duplication of the MILL gene in leukemic cells of a patient with acute myelogenous leukemia , 1998, Genes, chromosomes & cancer.

[22]  C. Preudhomme,et al.  17p Deletion in acute myeloid leukemia and myelodysplastic syndrome. Analysis of breakpoints and deleted segments by fluorescence in situ. , 1998, Blood.

[23]  K. Choo.  Centromere DNA dynamics: latent centromeres and neocentromere formation. , 1997, American journal of human genetics.

[24]  H. Drexler,et al.  Identity of original and late passage Dami megakaryocytes with HEL erythroleukemia cells shown by combined cytogenetics and DNA fingerprinting , 1997, Leukemia.

[25]  J. Chang,et al.  Aberrant FHIT transcripts in acute myeloid leukaemia , 1997, British journal of haematology.

[26]  N. Zhao,et al.  dic(5;17): A recurring abnormality in malignant myeloid disorders associated with mutations of TP53 , 1997, Genes, chromosomes & cancer.

[27]  H. Drexler,et al.  Early contamination of the Dami cell line by HEL. , 1997, Blood.

[28]  G. Dewald,et al.  Hematologic disorders associated with deletions of chromosome 20q: a clinicopathologic study of 107 patients. , 1996, American journal of clinical pathology.

[29]  J. Rowley,et al.  The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[30]  T. Manshouri,et al.  p16INK4A and p15INK4B gene deletions in primary leukemias. , 1995, Blood.

[31]  A. Klein-Szanto,et al.  Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. , 1994, Cancer research.

[32]  D. Rosenthal,et al.  Characterization of a new megakaryocytic cell line: the Dami cell. , 1988, Blood.

[33]  R. Bernstein,et al.  Fourth International Workshop on Chromosomes in Leukemia 1982: Abnormalities of chromosome 7 resulting in monosomy 7 or in deletion of the long arm (7q-): review of translocations, breakpoints, and associated abnormalities. , 1984, Cancer genetics and cytogenetics.

[34]  T. Papayannopoulou,et al.  HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression. , 1982, Science.

[35]  M. Cohen,et al.  Chromosome deletion (46, XY, 20q-) in sideroblastic anemia. , 1974, Israel journal of medical sciences.

[36]  P. Nowell,et al.  Chromosome preparations of leukocytes cultured from human peripheral blood. , 1960, Experimental cell research.

[37]  B. Mcclintock,et al.  The Stability of Broken Ends of Chromosomes in Zea Mays. , 1941, Genetics.

[38]  M. Seabright.  The use of proteolytic enzymes for the mapping of structural rearrangements in the chromosomes of man , 2004, Chromosoma.

[39]  T. Manshouri,et al.  Loss of heterozygosity on chromosome 5 in adults with acute lymphoblastic leukemia. , 2001, Leukemia research.

[40]  A. Look,et al.  Amplification of the E2F1 transcription factor gene in the HEL erythroleukemia cell line. , 1995, Genomics.

[41]  P. Meltzer,et al.  Telomere capture stabilizes chromosome breakage , 1993, Nature Genetics.

[42]  C. Morris,et al.  Nonrandom cytogenetic changes in New Zealand patients with acute myeloid leukemia. , 1983, Cancer genetics and cytogenetics.

[43]  Iscn.  International System for Human Cytogenetic Nomenclature , 1978 .

[44]  J. Rowley,et al.  Deletion of the long arm of chromosome 20 [del(20)(q11)] in myeloid disorders. , 1978, Blood.